CYP19A1 and breast carcinoma: Our goal was to identify patients 30‐50 years in age at diagnosis of early stage breast cancer (SEER stage 0/1), since this population is unlikely to experience significant mortality from their cancer, and is generally prescribed tamoxifen if hormone therapy is considered appropriate (older, postmenopausal patients are prescribed aromatase inhibitors).